Multiple immune and stromal cell populations in ocular tissues

Multiple immune and stromal cell populations in ocular tissues refers to the diverse collection of cells that constitute the ocular microenvironment, including leukocytes such as macrophages, T-cells, and B-cells, as well as structural cells like fibroblasts, keratocytes, and pericytes. These populations are fundamental to maintaining the eye's immune privilege and structural integrity, playing pivotal roles in the response to injury and infection (Source: PubMed, PMID: 33053334). In pathological states such as uveitis, age-related macular degeneration, and diabetic retinopathy, these cells undergo phenotypic shifts that drive inflammation, fibrosis, and neovascularization (Source: Nature Communications, 2020). While these cell populations are the site of action for many ophthalmic drugs, the term itself is a biological descriptor rather than a single molecular target like a receptor or enzyme. Consequently, therapeutic strategies often focus on specific signaling pathways or surface markers expressed by these cells rather than the entire population as a monolithic target (Source: NIH, National Eye Institute). Understanding the heterogeneity of these populations through single-cell transcriptomics has become a cornerstone for identifying novel cell-specific therapeutic interventions (Source: UniProt, Ocular Tissues context). Drugs like corticosteroids or anti-VEGF agents interact with specific receptors or ligands within this environment to modulate the behavior of these cell populations.

Other names

Ocular immune microenvironmentOcular stromal compartmentOcular cell atlasUveal and retinal cell populations

Not applicable for a cellular population; pharmacological agents target specific molecular components (e.g., cytokines or receptors) within these cells.